Among the species tested are Japanese eel, sturgeon, and bluefin tuna.
Umami Bioworks
Umami Bioworks has announced the expansion of its cultivated PDRN capabilities through its Marine Radiance™ platform, which uses cultivated marine biology (cultivated marine cells) to create and scale high-performance regenerative cosmetic actives.
Polydeoxyribonucleotide (PDRN) is produced from salmon milt (sperm), and despite its high DNA content, it has traditionally been treated as a low-value byproduct of the seafood industry.
By contrast, Umami Bioworks is working to unlock access to DNA-rich marine species that have never before been commercially viable sources of PDRN. The Singapore-based company aims to provide a "consistent, animal-free, and scalable" alternative to high-quality marine biology.
"We do believe that if supply were not a constraint, we could be exploring far more powerful marine sources, and that is exactly what cultivated technology allows us to do," assured Product & Strategy Manager at Umami Bioworks Gayathri Mani.
Specifically, Marine Radiance™ has enabled studies involving Japanese eel, sturgeon, and bluefin tuna, evaluating their biological performance against traditional salmon-derived PDRN. Early findings point to the potential emergence of a new class of premium, species-specific PDRN actives.
Umami Bioworks aims to enter into commercial agreements with cosmetic manufacturers and formulation partners across Asia and other regions to commercialize this concept and qualitatively elevate skincare through advanced regenerative formulations.
In October, it launched the world's first line of cultivated marine supplements, also under its Marine Radiance™ solution and supported by its ALKEMYST™ AI platform.